Shay Capital’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $119K | Sell |
32,954
-28,170
| -46% | -$101K | 0.01% | 220 |
|
|
2025
Q1 | $183K | Buy |
61,124
+30,491
| +100% | +$91.2K | 0.03% | 179 |
|
|
2024
Q4 | $103K | Buy |
30,633
+12,871
| +72% | +$43.1K | 0.02% | 217 |
|
|
2024
Q3 | $59.5K | Sell |
17,762
-6,424
| -27% | -$21.5K | 0.01% | 222 |
|
|
2024
Q2 | $80.1K | Buy |
24,186
+6,020
| +33% | +$19.9K | 0.01% | 204 |
|
|
2024
Q1 | $73.4K | Sell |
18,166
-31,973
| -64% | -$129K | 0.01% | 250 |
|
|
2023
Q4 | $153K | Buy |
50,139
+1,504
| +3% | +$4.59K | 0.03% | 154 |
|
|
2023
Q3 | $146K | Buy |
48,635
+14,000
| +40% | +$42K | 0.02% | 190 |
|
|
2023
Q2 | $130K | Buy |
+34,635
| New | +$130K | 0.02% | 229 |
|